Clinical Trial Details
— Status: Not yet recruiting
Administrative data
| NCT number |
NCT03193242 |
| Other study ID # |
10-052A |
| Secondary ID |
|
| Status |
Not yet recruiting |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
December 1, 2024 |
| Est. completion date |
June 1, 2026 |
Study information
| Verified date |
May 2023 |
| Source |
Unity Health Toronto |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
This study is an extension of a pilot study in which investigators developed and tested a
computerized tool to help physicians to determine if their patients' asthma is well
controlled, advise them on medication changes required according to the current level of
control, and automatically generate an electronic version of the AAP, all based on patient
responses to a questionnaire completed by patients on a tablet computer. In this phase
patients will have the ability to complete the questionnaire on their smartphones, through a
pre-downloaded app and will have access to an electronic asthma self-management app.
Description:
Asthma is a common and potentially fatal chronic disease. An asthma action plan (AAP) is a
written plan produced by a physician for a patient with asthma, to provide education and
guidelines for self-management of worsening asthma symptoms. Studies have shown that AAPs
effectively improve asthma control, but physicians fail to provide AAPs due to lack of time
and adequate skills. Physicians also often fail to determine if their patients have good
asthma control, and to adjust medications in response to patients' control level.
In a pilot study investigators developed and tested a computerized tool to help physicians to
determine if their patients' asthma is well controlled, advise them on medication changes
required according to the current level of control, and automatically generate an electronic
version of the AAP, all based on patient responses to a questionnaire completed by patients
on a tablet computer. In the pilot, investigators found that the tablet computers add a level
of complexity to clinic flow. In this study patients will have the ability to complete the
questionnaire on their smartphones, through a pre-downloaded app. Patients will also have
access to an electronic asthma self-management tool called Breathe through which they can
view their AAP and other asthma educational information.
The investigators hope that this system will eliminate the barriers that physicians face in
determining asthma control, adjusting medications, and delivering an AAP, and will increase
the frequency with which physicians are able to achieve these goals in patients with asthma.
The objectives of the study are to determine the impact of this system on asthma action plan
delivery by primary care physicians, the frequency of checking control level, and the
frequency and appropriateness of asthma medication changes (in accordance with control). The
investigators will also attempt to determine the impact of the system on hospitalisations,
emergency room (ER) visits, unscheduled visits to the doctor, total visits to the doctor,
days off work or school, nocturnal asthma symptoms, daytime asthma symptoms, daytime rescue
puffer use, and quality of life, and to measure physicians' perceptions of and satisfaction
with the system.
